References
- Fontana, F. Traite sur le Venin de la Viper, sur les Poisons Americains, sur le Laurier-Cerise et sur quelques autres Poisons Vegetaux; Gibelin: Florence, 1781.
- Montgomery, T H. Comparative cytological studies, with especial regard to the morphology of the nucleolus.J. Morphol. 1898, 15, 265–582. [CSA]
- Zahcarias, E. Ueber Eiweiss, nuclein und plastin.Bot. Ztg. 1883, 41, 209–215. [CSA]
- Heitz, E. Nukleolen und chromosomen in der Gattung Vicia.Planta 1931, 15. [CSA], [CROSSREF]
- McClintock, B. The relationship of a particular chrmosomal element to the development of the nucleoli in Zea mays.Zeit. Zellforsch. Mik. Anat. 1934, 21, 294–328. [CSA], [CROSSREF]
- Howell, W. Selective Staining of Nucleolar Organizing Regions (NORs); Academic: New York, 1982.
- Jordan, E G. Nucleolar nomenclature.J. Cell. Sci. 1984, 67, 217–220. [PUBMED], [INFOTRIEVE], [CSA]
- Dimova, R N.; Markov, D V.; Gajdardjieva, K C.; Dabeva, M D.; Hadjiolov, A A. Electron microscopic localization of silver staining NOR-proteins in rat liver nucleoli upon D-galactosamine block of transcription.Eur. J. Cell Biol. 1982, 28, 272–277. [PUBMED], [INFOTRIEVE], [CSA]
- Gas, N.; Escande, M L.; Stevens, B J. Immunolocalization of the 100 kDa nucleolar protein during the mitotic cycle in CHO cells.Biol. Cell 1985, 53, 209–218. [PUBMED], [INFOTRIEVE], [CSA]
- Rose, K M.; Szopa, J.; Han, F S.; Cheng, Y C.; Richter, A.; Scheer, U. Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription.Chromosoma 1988, 96, 411–416. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thiry, M.; Thiry-Blaise, L. In situ hybridization at the electron microscope level: an improved method for precise localization of ribosomal DNA and RNA.Eur. J. Cell Biol. 1989, 50, 235–243. [PUBMED], [INFOTRIEVE], [CSA]
- Dabauvalle, M C.; Benavente, R.; Chaly, N. Monoclonal antibodies to a Mr 68,000 pore complex glycoprotein interfere with nuclear protein uptake in Xenopus oocytes.Chromosoma 1988, 97, 193–197. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ochs, R L.; Lischwe, M A.; Shen, E.; Carroll, R E.; Busch, H. Nucleologenesis: composition and fate of prenucleolar bodies.Chromosoma 1985, 92, 330–336. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Benavente, R.; Schmidt-Zachmann, M S.; Hugle-Dorr, B.; Reimer, G.; Rose, K M.; Scheer, U. Identification and definition of nucleolus-related fibrillar bodies in micronucleated cells.Exp. Cell Res. 1988, 178, 518–523. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Benavente, R.; Rose, K M.; Reimer, G.; Hugle-Dorr, B.; Scheer, U. Inhibition of nucleolar reformation after microinjection of antibodies to RNA polymerase I into mitotic cells.J. Cell Biol. 1987, 105, 1483–1491. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Benavente, R.; Reimer, G.; Rose, K M.; Hugle-Dorr, B.; Scheer, U. Nucleolar changes after microinjection of antibodies to RNA polymerase I into the nucleus of mammalian cells.Chromosoma 1988, 97, 115–123. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ploton, D.; Thiry, M.; Menager, M.; Lepoint, A.; Adnet, J J.; Goessens, G. Behaviour of nucleolus during mitosis. A comparative ultrastructural study of various cancerous cell lines using the Ag-NOR staining procedure.Chromosoma 1987, 95, 95–107. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Warner, J R. The nucleolus and ribosome formation.Curr. Opin. Cell Biol. 1990, 2, 521–527. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goodpasture, C.; Bloom, S E. Visualization of nucleolar organizer regions im mammalian chromosomes using silver staining.Chromosoma 1975, 53, 37–50. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hernandez-Verdun, D.; Hubert, J.; Bourgeois, C A.; Bouteille, M. Ultrastructural localization of Ag-NOR stained proteins in the nucleolus during the cell cycle and in other nucleolar structures.Chromosoma 1980, 79, 349–362. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hernandez-Verdun, D. Structural organization of the nucleolus in mammalian cells.Methods Achiev. Exp. Pathol. 1986, 12, 26–62. [PUBMED], [INFOTRIEVE], [CSA]
- Roussel, P.; Belenguer, P.; Amalric, F.; Hernandez-Verdun, D. Nucleolin is an Ag-NOR protein; this property is determined by its amino-terminal domain independently of its phosphorylation state.Exp. Cell Res. 1992, 203, 259–269., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Roussel, P.; Hernandez-Verdun, D. Identification of Ag-NOR proteins, markers of proliferation related to ribosomal gene activity.Exp. Cell Res. 1994, 214, 465–472. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Derenzini, M.; Pession, A.; Trere, D. Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells.Lab. Invest. 1990, 63, 137–140. [PUBMED], [INFOTRIEVE], [CSA]
- Aubele, M.; Biesterfeld, S.; Derenzini, M.; Hufnagl, P.; Martin, H.; Ofner, D.; Ploton, D.; Ruschoff, J. Guidelines of AgNOR quantitation. Committee on AgNOR Quantitation within the European Society of Pathology.Zentralbl. Pathol. 1994, 140, 107–108. [PUBMED], [INFOTRIEVE], [CSA]
- Trere, D. AgNOR staining and quantification.Micron 2000, 31, 127–131. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Derenzini, M.; Trere, D. Standardization of interphase Ag-NOR measurement by means of an automated image analysis system using lymphocytes as an internal control.J. Pathol. 1991, 165, 337–342. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Crocker, J.; Boldy, D A.; Egan, M J. How should we count AgNORS? Proposals for a standardized approach.J. Pathol. 1989, 158, 185–188.. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Trere, D.; Migaldi, M.; Trentini, G P. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification.Anal. Cell. Pathol. 1995, 8, 57–65. [PUBMED], [INFOTRIEVE], [CSA]
- Ruschoff, J.; Plate, K H.; Contractor, H.; Kern, S.; Zimmermann, R.; Thomas, C. Evaluation of nucleolus organizer regions (NORs) by automatic image analysis: a contribution to standardization.J. Pathol. 1990, 161, 113–118. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Derenzini, M.; Nardi, F.; Farabegoli, F.; Ottinetti, A.; Roncaroli, F.; Bussolati, G. Distribution of silver-stained interphase nucleolar organizer regions as a parameter to distinguish neoplastic from nonneoplastic reactive cells in human effusions.Acta Cytol. 1989, 33, 491–498. [PUBMED], [INFOTRIEVE], [CSA]
- Pich, A.; Chiusa, L.; Margaria, E. Prognostic relevance of AgNORs in tumor pathology.Micron 2000, 31, 133–141. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Giri, D D.; Nottingham, J F.; Lawry, J.; Dundas, S A.; Underwood, J C. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.J. Pathol. 1989, 157, 307–313. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Aaltomaa, S.; Lipponen, P.; Syrjanen, K. Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer.Pathol. Res. Pract. 1993, 189, 416–421. [PUBMED], [INFOTRIEVE], [CSA]
- Lipponen, P K.; Eskelinen, M J.; Nordling, S. Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.Br. J. Cancer 1991, 64, 1139–1144. [PUBMED], [INFOTRIEVE], [CSA]
- Griffiths, A P.; Cross, D.; Kingston, R E.; Harkin, P.; Wells, M.; Quirke, P. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.Int. J. Gynecol. Pathol. 1993, 12, 307–314. [PUBMED], [INFOTRIEVE], [CSA]
- Mourad, W A.; Connelly, J H.; Sembera, D L.; Atkinson, E N.; Bruner, J M. The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain.Human Pathol. 1993, 24, 206–210. [CSA], [CROSSREF]
- Orita, T.; Kajiwara, K.; Nishizaki, T.; Ikeda, N.; Kamiryo, T.; Aoki, H. Nucleolar organizer regions in meningioma.Neurosurgery 1990, 26, 43–46. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Leek, R D.; Alison, M R.; Sarraf, C E. Variations in the occurrence of silverstaining nucleolar organizer regions (AgNORs) in non-proliferating and proliferating tissues.J. Pathol. 1991, 165, 43–51. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kuratsu, S.; Tomita, Y.; Myoui, A.; Uchida, A.; Ono, K.; Aozasa, K. DNA ploidy pattern and cell cycle stage of tumor cells in soft-tissue sarcomas: clinical implications.Oncology 1995, 52, 363–370. [PUBMED], [INFOTRIEVE], [CSA]
- Crocker, J.; Macartney, J C.; Smith, P J. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.J. Pathol. 1988, 154, 151–156. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ritossa, F M.; Spiegelman, S. Localization of DNA complementary to ribosomal RNA in the nucleolus organizer region of drosophila melanogaster.Proc. Natl. Acad. Sci. U. S. A. 1965, 53, 737–745. [PUBMED], [INFOTRIEVE], [CSA]
- Birnstiel, M L.; Chipchase, M I.; Hyde, B B. The nucleolus, a source of ribosomes.Biochim. Biophys. Acta 1963, 76, 454–462. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sonenberg, N.; Hershey, J W.B.; Mathews, M. Translational Control of Gene Expression, 2nd Ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2000.
- Pandolfi, P P. Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age.Oncogene 2004, 23, 3134–3137. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sherr, C J. Mammalian G1 cyclins and cell cycle progression.Proc. Assoc. Am. Physicians 1995, 107, 181–186. [PUBMED], [INFOTRIEVE], [CSA]
- Terada, N.; Patel, H R.; Takase, K.; Kohno, K.; Nairn, A C.; Gelfand, E W. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins.Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 11477–11481. [PUBMED], [INFOTRIEVE], [CSA]
- Jefferies, H B.; Reinhard, C.; Kozma, S C.; Thomas, G. Rapamycin selectively represses translation of the “polypyrimidine tract” mRNA family.Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 4441–4445. [PUBMED], [INFOTRIEVE], [CSA]
- Jefferies, H B.; Fumagalli, S.; Dennis, P B.; Reinhard, C.; Pearson, R B.; Thomas, G. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.EMBO J. 1997, 16, 3693–3704. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tenenbaum, S A.; Lager, P J.; Carson, C C.; Keene, J D. Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.Methods 2002, 26, 191–198. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tenenbaum, S A.; Carson, C C.; Lager, P J.; Keene, J D. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays.Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 14085–14090. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Holland, E C.; Sonenberg, N.; Pandolfi, P P.; Thomas, G. Signaling control of mRNA translation in cancer pathogenesis.Oncogene 2004, 23, 3138–3144. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Meyuhas, O. Synthesis of the translational apparatus is regulated at the translational level.Eur. J. Biochem. 2000, 267, 6321–6330. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Intine, R V.; Tenenbaum, S A.; Sakulich, A L.; Keene, J D.; Maraia, R J. Differential phosphorylation and subcellular localization of La RNPs associated with precursor tRNAs and translation-related mRNAs.Mol. Cell 2003, 12, 1301–1307. [PUBMED], [INFOTRIEVE], [CSA]
- Keene, J D. Posttranscriptional generation of macromolecular complexes.Mol. Cell 2003, 12, 1347–1349. [PUBMED], [INFOTRIEVE], [CSA]
- Amsterdam, A.; Sadler, K C.; Lai, K.; Farrington, S.; Bronson, R T.; Lees, J A.; Hopkins, N. Many ribosomal protein genes are cancer genes in zebrafish.PLoS Biol. 2004, 2, E139. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ruggero, D.; Grisendi, S.; Piazza, F.; Rego, E.; Mari, F.; Rao, P H.; Cordon-Cardo, C.; Pandolfi, P P. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.Science 2003, 299, 259–262. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ruggero, D.; Pandolfi, P P. Does the ribosome translate cancer?Nat. Rev., Cancer 2003, 3, 179–192. [CSA], [CROSSREF]
- Da Costa, L.; Willig, T N.; Fixler, J.; Mohandas, N.; Tchernia, G. Diamond-Blackfan anemia.Curr. Opin. Pediatr. 2001, 13, 10–15. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Draptchinskaia, N.; Gustavsson, P.; Andersson, B.; Pettersson, M.; Willig, T N.; , et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia.Nat. Genet. 1999, 21, 169–175. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bassoe, C F.; Bruserud, O.; Pryme, I F.; Vedeler, A. Ribosomal proteins sustain morphology, function and phenotype in acute myeloid leukemia blasts.Leuk. Res. 1998, 22, 329–339. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Uechi, T.; Tanaka, T.; Kenmochi, N. A complete map of the human ribosomal protein genes: assignment of 80 genes to the cytogenetic map and implications for human disorders.Genomics 2001, 72, 223–230. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Alon, U.; Barkai, N.; Notterman, D A.; Gish, K.; Ybarra, S.; Mack, D.; Levine, A J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays.Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 6745–6750., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang, L.; Zhou, W.; Velculescu, V E.; Kern, S E.; Hruban, R H.; Hamilton, S R.; Vogelstein, B.; Kinzler, K W. Gene expression profiles in normal and cancer cells.Science 1997, 276, 1268–1272. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kondoh, N.; Shuda, M.; Tanaka, K.; Wakatsuki, T.; Hada, A.; Yamamoto, M. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma.AntiCancer Res. 2001, 21, 2429–2433. [PUBMED], [INFOTRIEVE], [CSA]
- Loging, W T.; Reisman, D. Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53.Cancer Epidemiol. Biomark. Prev. 1999, 8, 1011–1016. [CSA]
- Ferrari, S.; Tagliafico, E.; Manfredini, R.; Grande, A.; Rossi, E.; Zucchini, P.; Torelli, G.; Torelli, U. Abundance of the primary transcript and its processed product of growth-related genes in normal and leukemic cells during proliferation and differentiation.Cancer Res. 1992, 52, 11–16. [PUBMED], [INFOTRIEVE], [CSA]
- Ferrari, S.; Manfredini, R.; Tagliafico, E.; Rossi, E.; Donelli, A.; Torelli, G.; Torelli, U. Noncoordinated expression of S6, S11, and S14 ribosomal protein genes in leukemic blast cells.Cancer Res. 1990, 50, 5825–5828. [PUBMED], [INFOTRIEVE], [CSA]
- Elit, L. CCI-779 Wyeth.Curr. Opin. Investig. Drugs 2002, 3, 1249–1253. [PUBMED], [INFOTRIEVE], [CSA]
- Hidalgo, M.; Rowinsky, E K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.Oncogene 2000, 19, 6680–6686. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Huang, S.; Houghton, P J. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic.Curr. Opin. Investig. Drugs 2002, 3, 295–304. [PUBMED], [INFOTRIEVE], [CSA]
- Fingar, D C.; Blenis, J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.Oncogene 2004, 23, 3151–3171. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gingras, A C.; Raught, B.; Sonenberg, N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.Annu. Rev. Biochem. 1999, 68, 913–963. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- De Benedetti, A.; Harris, A L. eIF4E expression in tumors: its possible role in progression of malignancies.Int. J. Biochem. Cell Biol. 1999, 31, 59–72. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Anand, N.; Murthy, S.; Amann, G.; Wernick, M.; Porter, L A.; , et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer.Nat. Genet. 2002, 31, 301–305. [PUBMED], [INFOTRIEVE], [CSA]
- Cantley, L C.; Neel, B G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 4240–4245. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Di Cristofano, A.; Pandolfi, P P. The multiple roles of PTEN in tumor suppression.Cell 2000, 100, 387–390. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kwiatkowski, D J. Tuberous sclerosis: from tubers to mTOR.Ann. Hum. Genet. 2003, 67, 87–96. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Quelle, D E.; Zindy, F.; Ashmun, R A.; Sherr, C J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.Cell 1995, 83, 993–1000. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Quelle, D E.; Ashmun, R A.; Hannon, G J.; Rehberger, P A.; Trono, D.; , et al. Cloning and characterization of murine p16INK4a and p15INK4b genes.Oncogene 1995, 11, 635–645. [PUBMED], [INFOTRIEVE], [CSA]
- Sharpless, N E.; DePinho, R A. The INK4A/ARF locus and its two gene products.Curr. Opin. Genet. Dev. 1999, 9, 22–30. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sherr, C J. Tumor surveillance via the ARF-p53 pathway.Genes Dev. 1998, 12, 2984–2991. [PUBMED], [INFOTRIEVE], [CSA]
- Hewitt, C.; Lee Wu, C.; Evans, G.; Howell, A.; Elles, R G.; Jordan, R.; Sloan, P.; Read, A P.; Thakker, N. Germline mutation of ARF in a melanoma kindred.Hum. Mol. Genet. 2002, 11, 1273–1279. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nakamura, M.; Watanabe, T.; Klangby, U.; Asker, C.; Wiman, K.; Yonekawa, Y.; Kleihues, P.; Ohgaki, H. p14ARF deletion and methylation in genetic pathways to glioblastomas.Brain Pathol. 2001, 11, 159–168. [PUBMED], [INFOTRIEVE], [CSA]
- Rizos, H.; Puig, S.; Badenas, C.; Malvehy, J.; Darmanian, A P.; Jimenez, L.; Mila, M.; Kefford, R F. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.Oncogene 2001, 20, 5543–5547. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rizos, H.; Darmanian, A P.; Holland, E A.; Mann, G J.; Kefford, R F. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.J. Biol. Chem. 2001, 276, 41424–41434. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- de Stanchina, E.; McCurrach, M E.; Zindy, F.; Shieh, S Y.; Ferbeyre, G.; , et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor.Genes Dev. 1998, 12, 2434–2442. [PUBMED], [INFOTRIEVE], [CSA]
- Cong, F.; Zou, X.; Hinrichs, K.; Calame, K.; Goff, S P. Inhibition of v-Abl transformation by p53 and p19ARF.Oncogene 1999, 18, 7731–7739. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Inoue, K.; Wen, R.; Rehg, J E.; Adachi, M.; Cleveland, J L.; Roussel, M F.; Sherr, C J. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.Genes Dev. 2000, 14, 1797–1809. [PUBMED], [INFOTRIEVE], [CSA]
- Inoue, K.; Roussel, M F.; Sherr, C J. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1.Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 3993–3998. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Raveh, T.; Droguett, G.; Horwitz, M S.; DePinho, R A.; Kimchi, A. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.Nat. Cell Biol. 2001, 3, 1–7. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ries, S.; Biederer, C.; Woods, D.; Shifman, O.; Shirasawa, S.; Sasazuki, T.; McMahon, M.; Oren, M.; McCormick, F. Opposing effects of Ras on p53: transcriptional activation of MDM2 and induction of p19ARF.Cell 2000, 103, 321–330. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weber, J D.; Taylor, L J.; Roussel, M F.; Sherr, C J.; Bar-Sagi, D. Nucleolar ARF sequesters Mdm2 and activates p53.Nat. Cell Biol. 1999, 1, 20–26. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Honda, R.; Tanaka, H.; Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.FEBS Lett. 1997, 420, 25–27. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weber, J D.; Kuo, M L.; Bothner, B.; DiGiammarino, E L.; Kriwacki, R W.; Roussel, M F.; Sherr, C J. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.Mol. Cell. Biol. 2000, 20, 2517–2528. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lohrum, M A.; Ashcroft, M.; Kubbutat, M H.; Vousden, K H. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.Curr. Biol. 2000, 10, 539–542. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lohrum, M A.; Ashcroft, M.; Kubbutat, M H.; Vousden, K H. Identification of a cryptic nucleolar-localization signal in MDM2.Nat. Cell Biol. 2000, 2, 179–181. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kamijo, T.; Bodner, S.; van de Kamp, E.; Randle, D H.; Sherr, C J. Tumor spectrum in ARF-deficient mice.Cancer Res. 1999, 59, 2217–2222. [PUBMED], [INFOTRIEVE], [CSA]
- Gudas, J.; Nguyen, H.; Li, T.; Hill, D.; Cowan, K H. Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells.Oncogene 1995, 11, 253–261. [PUBMED], [INFOTRIEVE], [CSA]
- Jacks, T.; Shih, T S.; Schmitt, E M.; Bronson, R T.; Bernards, A.; Weinberg, R A. Tumour predisposition in mice heterozygous for a targeted mutation in NF1.Nat. Genet. 1994, 7, 353–361. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kamijo, T.; Zindy, F.; Roussel, M F.; Quelle, D E.; Downing, J R.; Ashmun, R A.; Grosveld, G.; Sherr, C J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.Cell 1997, 91, 649–659. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weber, J D.; Jeffers, J R.; Rehg, J E.; Randle, D H.; Lozano, G.; Roussel, M F.; Sherr, C J.; Zambetti, G P. p53-independent functions of the p19(ARF) tumor suppressor.Genes Dev. 2000, 14, 2358–2365. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Foster, C J.; Lozano, G. Loss of p19ARF enhances the defects of MDM2 overexpression in the mammary gland.Oncogene 2002, 21, 3525–3531. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang, Y.; Zhang, Z.; Kastens, E.; Lubet, R A.; You, M. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.Cancer Res. 2003, 63, 4389–4395. [PUBMED], [INFOTRIEVE], [CSA]
- Caca, K.; Feisthammel, J.; Klee, K.; Tannapfel, A.; Witzigmann, H.; Wittekind, C.; Mossner, J.; Berr, F. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.Int. J. Cancer 2002, 97, 481–488. [PUBMED], [INFOTRIEVE], [CSA]
- Iida, S.; Akiyama, Y.; Nakajima, T.; Ichikawa, W.; Nihei, Z.; Sugihara, K.; Yuasa, Y. Alterations and hypermethylation of the p14(ARF) gene in gastric cancer.Int. J. Cancer 2000, 87, 654–658. [PUBMED], [INFOTRIEVE], [CSA]
- Kannan, K.; Krishnamurthy, J.; Feng, J.; Nakajima, T.; Tsuchida, N.; Shanmugam, G. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.Int. J. Oncol. 2000, 17, 1031–1035. [PUBMED], [INFOTRIEVE], [CSA]
- Eischen, C M.; Weber, J D.; Roussel, M F.; Sherr, C J.; Cleveland, J L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.Genes Dev. 1999, 13, 2658–2669. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sugimoto, M.; Kuo, M L.; Roussel, M F.; Sherr, C J. Nucleolar ARF tumor suppressor inhibits ribosomal RNA processing.Mol. Cell 2003, 11, 415–424. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pardee, A B. G1 events and regulation of cell proliferation.Science 1989, 246, 603–608. [PUBMED], [INFOTRIEVE], [CSA]
- Eichler, D C.; Craig, N. Processing of eukaryotic ribosomal RNA.Prog. Nucleic Acid Res. Mol. Biol. 1994, 49, 197–239. [PUBMED], [INFOTRIEVE], [CSA]
- Yung, B Y.; Busch, R K.; Busch, H.; Mauger, A B.; Chan, P K. Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1).Biochem. Pharmacol. 1985, 34, 4059–4063. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Spector, D L.; Ochs, R L.; Busch, H. Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23.Chromosoma 1984, 90, 139–148. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lischwe, M A.; Smetana, K.; Olson, M O.; Busch, H. Proteins C23 and B23 are the major nucleolar silver staining proteins.Life Sci. 1979, 25, 701–708. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Okuda, M.; Horn, H F.; Tarapore, P.; Tokuyama, Y.; Smulian, A G.; , et al. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.Cell 2000, 103, 127–140. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Feuerstein, N.; Spiegel, S.; Mond, J J. The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody.J. Cell Biol. 1988, 107, 1629–1642. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bullrich, F.; Morris, S W.; Hummel, M.; Pileri, S.; Stein, H.; Croce, C M. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.Cancer Res. 1994, 54, 2873–2877. [PUBMED], [INFOTRIEVE], [CSA]
- Morris, S W.; Kirstein, M N.; Valentine, M B.; Dittmer, K G.; Shapiro, D N.; Saltman, D L.; Look, A T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.Science 1994, 263, 1281–1284. [CSA]
- Redner, R L.; Rush, E A.; Faas, S.; Rudert, W A.; Corey, S J. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.Blood 1996, 87, 882–886. [PUBMED], [INFOTRIEVE], [CSA]
- Yoneda-Kato, N.; Look, A T.; Kirstein, M N.; Valentine, M B.; Raimondi, S C.; Cohen, K J.; Carroll, A J.; Morris, S W. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.Oncogene 1996, 12, 265–275. [PUBMED], [INFOTRIEVE], [CSA]
- Bischof, D.; Pulford, K.; Mason, D Y.; Morris, S W. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPManaplastic lymphoma kinase fusion protein in oncogenesis.Mol. Cell. Biol. 1997, 17, 2312–2325. [PUBMED], [INFOTRIEVE], [CSA]
- Drexler, H G.; Gignac, S M.; von Wasielewski, R.; Werner, M.; Dirks, W G. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.Leukemia 2000, 14, 1533–1559. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bertwistle, D.; Sugimoto, M.; Sherr, C J. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.Mol. Cell. Biol. 2004, 24, 985–996. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Itahana, K.; Bhat, K P.; Jin, A.; Itahana, Y.; Hawke, D.; Kobayashi, R.; Zhang, Y. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.Mol. Cell 2003, 12, 1151–1164. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brady, S N.; Yu, Y.; Maggi, L B.; Weber, J D. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.Mol. Cell. Biol. 2004, 24. [CSA], [CROSSREF]
- Andersen, J S.; Lyon, C E.; Fox, A H.; Leung, A K.; Lam, Y W.; Steen, H.; Mann, M.; Lamond, A I. Directed proteomic analysis of the human nucleolus.Curr. Biol. 2002, 12, 1–11. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Leung, A K.; Andersen, J S.; Mann, M.; Lamond, A I. Bioinformatic analysis of the nucleolus.Biochem. J. 2003, 376, 553–569. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Andersen, J S.; Lam, Y W.; Leung, A K.; Ong, S E.; Lyon, C E.; Lamond, A I.; Mann, M. Nucleolar proteome dynamics.Nature 2005, 433, 77–83. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Scherl, A.; Coute, Y.; Deon, C.; Calle, A.; Kindbeiter, K.; Sanchez, J C.; Greco, A.; Hochstrasser, D.; Diaz, J J. Functional proteomic analysis of human nucleolus.Mol. Biol. Cell 2002, 13, 4100–4109. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Warner, J R. The economics of ribosome biosynthesis in yeast.Trends Biochem. Sci. 1999, 24, 437–440. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ljungman, M. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.Neoplasia 2000, 2, 208–225. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pluquet, O.; Hainaut, P. Genotoxic and non-genotoxic pathways of p53 induction.Cancer Lett. 2001, 174, 1–15. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rubbi, C P.; Milner, J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.EMBO J. 2003, 22, 6068–6077. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Horn, H F.; Vousden, K H. Cancer: guarding the guardian?Nature 2004, 427, 110–111. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- David-Pfeuty, T. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.Oncogene 1999, 18, 7409–7422. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pestov, D G.; Grzeszkiewicz, T M.; Lau, L F. Isolation of growth suppressors from a cDNA expression library.Oncogene 1998, 17, 3187–3197. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pestov, D G.; Strezoska, Z.; Lau, L F. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein BOP1 on G(1)/S transition.Mol. Cell. Biol. 2001, 21, 4246–4255. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Strezoska, Z.; Pestov, D G.; Lau, L F. BOP1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5. 8S RRNA processing and 60S ribosome biogenesis.Mol. Cell. Biol. 2000, 20, 5516–5528. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Strezoska, Z.; Pestov, D G.; Lau, L F. Functional inactivation of the mouse nucleolar protein Bop1 inhibits multiple steps in pre-rRNA processing and blocks cell cycle progression.J. Biol. Chem. 2002, 277, 29617–29625. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]